NICE CG178 psychosis and schizophrenia in adults: Treatment and management - An evidence-based guideline?

British Journal of Psychiatry

Volumn 206, Issue 5, 2015, Pages 357-359

  Taylor, Mark ^a,b   Perera, Udayanga ^c  

^a ROYAL EDINBURGH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c District General Hospital   (Sri Lanka)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; NEUROLEPTIC AGENT;

ADULT; ART THERAPY; BIPOLAR I DISORDER; COGNITIVE REMEDIATION THERAPY; COGNITIVE THERAPY; DELUSIONAL DISORDER; EDITORIAL; EVIDENCE BASED PRACTICE; FAMILY THERAPY; HELP SEEKING BEHAVIOR; HUMAN; PATIENT COUNSELING; PRACTICE GUIDELINE; PSYCHOANALYSIS; PSYCHODYNAMIC PSYCHOTHERAPY; PSYCHOEDUCATION; PSYCHOSIS; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SCHIZOPHRENIFORM DISORDER; SOCIAL ADAPTATION; SUPPORTIVE THERAPY; DISEASE MANAGEMENT; EVIDENCE BASED MEDICINE; PROCEDURES; PSYCHOTIC DISORDERS; STANDARDS;

ADULT; ANTIPSYCHOTIC AGENTS; COGNITIVE THERAPY; DISEASE MANAGEMENT; EVIDENCE-BASED MEDICINE; HUMANS; PRACTICE GUIDELINES AS TOPIC; PSYCHOTIC DISORDERS; SCHIZOPHRENIA;

EID: 84929378772     PISSN: 00071250     EISSN: 14721465     Source Type: Journal    
DOI: 10.1192/bjp.bp.114.155945     Document Type: Editorial

References (18)

1. Thacker S, Johnson J. How nasty has NICE been to people with dementia? Psychiatr Bull 2008; 32: 32.
2. National Collaborating Centre for Mental Health. Psychosis and Schizophrenia in Adults: Treatment and Management. NICE Clinical Guideline 178. NICE, 2014 (http://www.nice.org.uk/guidance/cg178/evidence/cg178-psychosis-and-schizophrenia-in-adults-full-guideline3).
3. National Collaborating Centre for Mental Health. Schizophrenia: Core Interventions in the Treatment and Management of Schizophrenia in Adults in Primary and Secondary Care. NICE Clinical Guideline 82. NICE, 2009.
4. Scottish Intercollegiate Guidelines Network. Management of Schizophrenia: A National Clinical Guideline. SIGN 131. SIGN, 2013 (http://www.sign.ac.uk/pdf/sign131.pdf).
5. Tiihonen J, Lönnqvist J, Wahlbeck K, Klaukka T, Niskanen L, Tanskanen A, et al. 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet 2009; 374: 620-7.
6. Stafford MR, Jackson H, Mayo-Wilson E, Morrison AP, Kendall T. Early intervention to prevent psychosis: systematic review and meta-analysis. BMJ 2013; 346: f185.
7. Jauhar S, McKenna PJ. Radua J, Fung E, Salvador R, Laws KR. Cognitive-behavioural therapy for the symptoms of schizophrenia: systematic review and meta-analysis with examination of potential bias. Br J Psychiatry 2014; 204: 20-9.
8. National Collaborating Centre for Mental Health. Psychosis and Schizophrenia in Children and Young People: Recognition and Management. Clinical Guideline 155. NICE, 2013 (http://guidance.nice.org.uk/CG155).
9. Van Os J, Murray RM. Can we identify and treat "schizophrenia light" to prevent true psychotic illness? BMJ 2013; 346: f304.
10. Tsuang MT, Van Os J, Tandon R, Barch DM, Bustillo J, Gaebel W, et al. Attenuated psychosis syndrome in DSM-5. Schizophr Res 2013; 150: 31-5.
11. Morrison AP, French P, Stewart SL, Birchwood M, Fowler D, Gumley AI, et al. Early detection and intervention evaluation for people at risk of psychosis: multisite randomised controlled trial. BMJ 2012; 344: e2233.
12. Morrison AP, Turkington D, Pyle M, Spencer H, Brabban A, Dunn G, et al. Cognitive therapy for people with schizophrenia spectrum disorders not taking antipsychotic drugs: a single-blind randomised controlled trial. Lancet 2014; 383: 1395-403.
13. Coyne J. Much ado about a modest and misrepresented study of CBT for schizophrenia: Part 2. PloS Blogs 2014; 11 March (http://blogs.plos.org/mindthebrain/2014/03/11/much-ado-modest-misrepresented-trial-cbtschizophrenia-part-2/).
14. World Health Organization. Report of the International Pilot Study of Schizophrenia (Vol 1). World Health Organization, 1973.
15. Leucht S, Cipriani A, Spineli L, Mavridis D, Orey D, Richter F, et al. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet 2013; 382: 951-62.
16. Taylor D, Paton C, Kapur S. The Maudsley Prescribing Guidelines in Psychiatry (11th edn). John Wiley and Sons, 2009.
17. Barnes TRE and the Schizophrenia Consensus Group of the British Association for Psychopharmacology. Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for Psychopharmacology. J Psychopharmacol 2011; 25: 567-620 (http://www.bap.org.uk/pdfs/Schizophrenia-Consensus-Guideline-Document.pdf).
18. Crawford MJ, Killaspy H, Barnes TRE, Barrett B, Byford S, Clayton K, et al. Group art therapy as an adjunctive treatment for people with schizophrenia: multicentre pragmatic randomised trial. BMJ 2012; 344: e846.